Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
An AAV-SGCG Dose-Response Study in a gamma-Sarcoglycanopathy Mouse Model in the Context of Mechanical Stress.
Israeli D, Cosette J, Corre G, et al.
Molecular therapy. Methods & clinical development, 2019, 13, p 494
Natural history of LGMD2A for delineating outcome measures in clinical trials
Richard I, Hogrel JY, Stockholm D, et al.
Annals of clinical and translational neurology, 2016, 3, 4, p 248
Single Cell Dynamics Causes Pareto-Like Effect in Stimulated T Cell Populations
Cosette J, Moussy A, Onodi F, et al.
Scientific Reports, 2015, 5
Stochastic fluctuations and distributed control of gene expression impact cellular memory
Corre G, Stockholm D, Arnaud O, et al.
PLoS ONE, 2014, 9, 12
A human skeletal muscle interactome centered on proteins involved in muscular dystrophies : LGMD interactome
Blandin G, Marchand S, Charton K, et al.
Skeletal Muscle, 2013, 3, 1, 3, p. 1-19
Lentiviral transduction of CD34+ cells induces genome-wide epigenetic modifications
Yamagata Y, Parietti V, Stockholm D, et al.
PLoS ONE, 2012, 7, 11, e48943
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy
Lostal W, Bartoli M, Roudaut C, et al.
PLoS ONE, 2012, 7, 5, e38036, 11 p.
AAV-mediated transfer of the dysferlin gene is efficient in protecting the muscle from eccentric contractions
Pryadkina M, Bourg N, Lostal W, et al.
Congrès : 4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France))
2011, p. 111
Dysferlin is more than a membrane repair protein : overexpression of myoferlin or transfer of a minidysferlin protein repair sarcolemmal lesion but do not prevent muscle dystrophy in a mouse model of dysferlinopathy (poster)
Carinne R, Lostal W, Bartoli M, et al.
Congrès : 4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France))
2011, p. 114
Real time fluorescence imaging of whole mouse muscle during eccentric exercise in vivo and in vitro : a new tool to study sarcolemmal disruption (poster)
Borel P, Guerchet N, Tanniou G, et al.
Congrès : 4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France))
2011, p. 136
Reversibility of the myogenic marker CD56 in human cells : a bistable expression dependent on stochastic fluctuations and spatial micro-environment
Stockholm D, Edom-Vovard F, Coutant S, et al.
Congrès : 4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France))
2011, p. 142
Size determination and quantification of sarcolemmal disruptions in muscle in an ageing dyferlin deficient mouse model (poster)
Borel P, Petiot J, de Dreuzy E, et al.
Congrès : 4th International Congress of Myology, 4ème colloque international de Myologie (in) (9-13 mai 2011; Lille (France))
2011, p. 118
DNAJB2 expression in normal and diseased human and mouse skeletal muscle
Claeys KG, Sozanska M, Martin JJ, et al.
American journal of pathology (The), 2010, 176, 6, p. 2901-2910
Epigenetic gene expression noise and phenotypic diversification of clonal cell populations
Neildez-Nguyen TM, Parisot A, Vignal C, et al.
Cell death and differentiation, 2008, 76, 1, p. 33-40
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells
Benjelloun F, Garrigue A, Demerens-de Chappedelaine C, et al.
Molecular therapy, 2008, 16, 8, p. 1490-1499
Muscle loss quantification by CT-scan analysis in the context of the natural history of calpainopathies project
Laurent E, Borel P, Hogrel JY, et al.
Congrès : Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France)
2008, p. 184
Natural history of calpainopathies
Urtizberea JA, De Munain LA, Mignard C, et al.
Congrès : Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France)
2008, p. 185
Combination of quantification and observation methods for study of Side Population cells in their in vitro microenvironment
Benchaouir R, Picot J, Greppo N, et al.
Cytometry A, 2007, 71, 4, p. 251-257
The origin of phenotypic heterogeneity in a clonal cell population in vitro
Stockholm D, Benchaouir R, Picot J, et al.
PLoS ONE, 2007, 2, 4, p. e394
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy : a balance between efficiency and toxicity
Lagresle-Peyrou C, Yates F, Malassis-Seris M, et al.
Artificial cells, blood substitutes and immobilization biotechnology, 2006, 107, 1, p. 63-72
A mouse model for monitoring calpain activity under physiological and pathological conditions
Bartoli M, Bourg N, Stockholm D, et al.
Journal of biological chemistry (The), 2006, 281, 51, p. 39672-39680
A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice
Charrier S, Stockholm D, Seye K, et al.
Gene therapy, 2005, 12, 7, p. 597-606
Imaging calpain protease activity by multiphoton FRET in living mice
Stockholm D, Bartoli M, Sillon G, et al.
Journal of molecular biology, 2005, 346, 1, p. 215-222
Bidirectional transcriptional activity of the Pgk1 promoter and transmission ratio distortion in Capn3-deficient mice
Taveau M, Stockholm D, Marchand S, et al.
Genomics, 2004, 84, 3, p. 592-595
Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice
Richard I, Roudaut C, Marchand S, et al.
The Journal of cell biology, 2000, 151, 7, p 1583
